Table 1.
VISTA in clinical trials.
| Medication | Cancer type | Status | Clinical trial phase | Location | Identifiers |
|---|---|---|---|---|---|
| CA-170 | Advanced solid tumors or lymphomas | Completed | Phase I | USA | NCT02812875 |
| CA-170 | lung cancer, head/neck/oral cavity cancer, MSI-H positive cancers, and Hodgkin lymphoma | Terminated | Phase II | India | CTRI/2017/12/011026 |
| JNJ-61610588 | Advanced tumors | Terminated | Phase I | USA | NCT02671955 |
| CI-8993 | Relapsed/refractory solid tumors | Recruiting | Phase I | USA | NCT04475523 |
MSI-H, microsatellite instability-high.